Amyloid immunotherapy for early Alzheimer’s: Promising but fraught with challenges In a recent perspective piece published in the Journal of the Alzheimer’s Association Alzheimer’s and dementiaresearchers from the United Kingdom…
Cambridge experts question efficacy and practicality of new amyloid immunotherapy drugs Cambridge researchers have raised doubts about whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the…
